<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Clinical and Basic Research</title>
<title_fa>Journal of Clinical and Basic Research</title_fa>
<short_title>jcbr</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jcbr.goums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2538-3736</journal_id_issn>
<journal_id_issn_online>2538-3736</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61186/jcbr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>9</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Incidence of breakthrough COVID-19 infection following non-mRNA vaccination among healthcare workers in educational hospitals in northeastern Iran</title>
	<subject_fa></subject_fa>
	<subject>Medicine </subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:12px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;b&gt;Background:&lt;/b&gt; While vaccines provide substantial protection against COVID-19, breakthrough infections remain a concern. This study aimed to determine the Incidence rate of post-vaccination COVID-19 infections among healthcare workers at teaching hospitals in Gorgan, Northeast Iran between 2020 and 2021.&lt;br&gt;
&lt;b&gt;Methods:&lt;/b&gt; In this cross-sectional study, we enrolled all 527 healthcare workers who had received at least one dose of non-mRNA COVID-19 vaccines. Vaccination data were systematically recorded and analyzed. COVID-19 infection was laboratory-confirmed by RT-PCR testing.&lt;br&gt;
&lt;b&gt;Results:&lt;/b&gt; The mean age of participants was 35.3&amp;plusmn;9.8 years. Breakthrough infections occurred in 255 participants (48.4%) after primary vaccination (First and second doses) and in 36 cases (6.83%) following booster doses. Incidence rates were significantly higher among internal medicine and infectious disease staff (p=0.006). Temporal analysis revealed peak infection incidence within 4 months post-primary vaccination, with the lowest rates observed &gt;4 months post-booster administration.&lt;br&gt;
&lt;b&gt;Conclusion&lt;/b&gt;: While breakthrough infections occurred in a substantial proportion of participants after primary vaccination, booster doses were associated with significantly lower infection rates. Further research is needed to assess the impact of vaccination status on disease severity.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>COVID-19, Vaccination, Breakthrough infection, Healthcare workers, Non-mRNA vaccines, Iran</keyword>
	<start_page>0</start_page>
	<end_page>0</end_page>
	<web_url>http://jcbr.goums.ac.ir/browse.php?a_code=A-10-55-8&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Samira</first_name>
	<middle_name></middle_name>
	<last_name> Eshginia </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Eshginia@yahoo.com</email>
	<code>10031947532846006642</code>
	<orcid>10031947532846006642</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Metabolic Disorders Research Center, Biomedical Research Institute, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Roghieh</first_name>
	<middle_name></middle_name>
	<last_name> Golsha </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Golsha@yahoo.com</email>
	<code>10031947532846006643</code>
	<orcid>10031947532846006643</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Infectious Diseases Research Center, Jorjani Clinical Sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran; Department of Infectious Diseases, 5th Azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran; Department of Infectious Diseases, Sayyad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Rahmatollah</first_name>
	<middle_name></middle_name>
	<last_name> Sharififar </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Sharififar@yahoo.com</email>
	<code>10031947532846006644</code>
	<orcid>0009-0008-7118-4026</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Infectious Diseases, 5th Azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran; Department of Infectious Diseases, Sayyad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Negar </first_name>
	<middle_name></middle_name>
	<last_name>Broumand</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Broumand@yahoo.com</email>
	<code>10031947532846006645</code>
	<orcid>10031947532846006645</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Surgery, 5th Azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name> Mehravar </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Mehravar10261@yahoo.com</email>
	<code>10031947532846006646</code>
	<orcid>10031947532846006646</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Ischemic Disorders Research Center, Jorjani Clinical Sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
